Publication:
bet.es study.

dc.contributor.authorRojo-Martínez, Gemma
dc.contributor.authorMaymó-Masip, Elsa
dc.contributor.authorRodríguez, M Mar
dc.contributor.authorSolano, Esther
dc.contributor.authorGoday, Albert
dc.contributor.authorSoriguer, Federico
dc.contributor.authorValdés, Sergio
dc.contributor.authorChaves, Felipe Javier
dc.contributor.authorDelgado, Elías
dc.contributor.authorColomo, Natalia
dc.contributor.authorHernández, Pilar
dc.contributor.authorVendrell, Joan
dc.contributor.authorChacón, Matilde R
dc.contributor.authoraffiliation[Rojo-Martínez,G; Soriguer,F; Valdés,S; Colomo,N] UGCI de Endocrinología y Nutrición, Instituto de Biomedicina de Málaga (IBIMA), Hospital Regional Universitario, Málaga, Spain. [Rojo-Martínez,G; Maymó-Masip,E; Solano,E; Soriguer,F; Valdés,S; Chaves,FJ; Colomo,N; Vendrell,J; Chacón,MR] Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas CIBERDEM, Barcelona, Spain. Maymó-Masip,E; Solano,E; Hernández,P; Vendrel,J; Chacón,MR] Hospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain. [Rodríguez,MM] CIBERObn Fisiopatología, Obesidad y Nutrición, Institut D’investigacio Biomedica De Girona Dr Josep Trueta, Girona, Spain. [Goday,A] Department of Endocrinology and Nutrition Hospital del Mar, Parc de Salut Mar, Universitat Autónoma de Barcelona, Barcelona, Spain. [Chaves,FJ] Genotyping and Genetic Diagnosis Unit, Fundación de Investigación del Hospital Clínico de Valencia-INCLIVA, Valencia, Spain. [Delgado,E] Departamento de Medicina-Endocrinología y Nutrición, Hospital Universitario Central de Asturias (HUCA), Universidad de Oviedo, Oviedo, Spain.
dc.date.accessioned2024-01-15T18:17:18Z
dc.date.available2024-01-15T18:17:18Z
dc.date.issued2014-06-30
dc.description.abstractOBJECTIVE: Serum levels of soluble TNF-like weak inducer of apoptosis (sTWEAK) and its scavenger receptor CD163 (sCD163) have been linked to insulin resistance. We analysed the usefulness of these cytokines as biomarkers of type 2 diabetes in a Spanish cohort, together with their relationship to food consumption in the setting of the Di@bet.es study. RESEARCH DESIGN AND METHODS: This is a cross-sectional, matched case-control study of 514 type 2 diabetes subjects and 517 controls with a Normal Oral Glucose Tolerance Test (NOGTT), using data from the Di@bet.es study. Study variables included clinical and demographic structured survey, food frequency questionnaire and physical examination. Serum concentrations of sTWEAK and sCD163 were measured by ELISA. Linear regression analysis determined which variables were related to sTWEAK and sCD163 levels. Logistic regression analysis was used to estimate odd ratios of presenting type 2 diabetes. RESULTS: sCD163 concentrations and sCD163/sTWEAK ratio were 11.0% and 15.0% higher, respectively, (P<0.001) in type 2 diabetes than in controls. Following adjustment for various confounders, the OR for presenting type 2 diabetes in subjects in the highest vs the lowest tertile of sCD163 was [(OR), 2,01 (95%CI, 1,46-2,97); P for trend <0.001]. Coffee and red wine consumption was negatively associated with serum levels of sCD163 (P = 0.0001 and; P = 0.002 for coffee and red wine intake, respectively). CONCLUSIONS: High circulating levels of sCD163 are associated with type 2 diabetes in the Spanish population. The association between coffee and red wine intake and these biomarkers deserves further study to confirm its potential role in type 2 diabetes.
dc.description.sponsorshipThis study was supported by projects from the Fondo de Investigación Sanitaria (FIS): PI 11/00049, PI 11/0085 and PI 11/02755 cofinanced by the European Regional Development Fund (ERDF). The Research Stabilization Programme of the Instituto de Salud Carlos III (ISCIII) co-financed by Institut Catala` de Salut (ICS) in Catalonia. Di@bet.es study was supported by CIBER in Diabetes and Associated Metabolic Disorders - CIBERDEM (ISCIII - Ministerio de Ciencia e Innovación), Ministerio de Sanidad and Spanish Society of Diabetes – SED.
dc.identifier.doi10.1371/journal.pone.0101250
dc.identifier.e-issn1932-6203es_ES
dc.identifier.journalPloS ONEes_ES
dc.identifier.otherhttp://hdl.handle.net/10668/1990
dc.identifier.pubmedID24978196es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/17071
dc.language.isoeng
dc.publisherPublic Library of Science (PLOS)
dc.relation.publisherversionhttp://journals.plos.org/plosone/article?id=10.1371/journal.pone.0101250es
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectCafé
dc.subjectDiabetes mellitus tipo II
dc.subjectConducta bebedora
dc.subjectHábitos alimenticios
dc.subjectFunciones de verosimilitud
dc.subjectSolubilidad
dc.subjectVino
dc.subjectEspaña
dc.subject.meshAntigens, Differentiation, Myelomonocytic
dc.subject.meshCoffee
dc.subject.meshDiabetes Mellitus, Type 2
dc.subject.meshDrinking Behavior
dc.subject.meshFemale
dc.subject.meshFood Habits
dc.subject.meshHumans
dc.subject.meshLikelihood Functions
dc.subject.meshMiddle Aged
dc.subject.meshReceptors, Cell Surface
dc.subject.meshSolubility
dc.subject.meshSpain
dc.subject.meshTumor Necrosis Factors
dc.subject.meshWine
dc.subject.meshAntigens, CD
dc.titleSerum sCD163 levels are associated with type 2 diabetes mellitus and are influenced by coffee and wine consumption: results of the Di@bet.es study.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isPublisherOfPublicationa2759e3d-0d58-4e8a-9fcd-c6130ee333d1
relation.isPublisherOfPublication.latestForDiscoverya2759e3d-0d58-4e8a-9fcd-c6130ee333d1

Files